Publication date: Available online 22 November 2018
Source: Trends in Endocrinology & Metabolism
Author(s): Eylem Kulkoyluoglu-Cotul, Alexandra Arca, Zeynep Madak-Erdogan
Estrogens and estrogen receptors (ERs) regulate metabolism in both normal physiology and in disease. The metabolic characteristics of intrinsic breast cancer subtypes change based on their ER expression. Crosstalk between estrogen signaling elements and several key metabolic regulators alters metabolism in breast cancer cells, and enables tumors to rewire their metabolism to adapt to poor perfusion, transient nutrient deprivation, and increased acidity. This leads to the selection of drug-resistant and metastatic clones. In this review we discuss studies revealing the role of estrogen signaling elements in drug resistance development and metabolic adaptation during breast cancer progression.
https://ift.tt/2POHPAe
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου